Applying Real-World Evidence in the Management of CAD/PAD : Episode 1

Video

February 1, 2021

Role of NOACs in Venous Thromboembolism and COMPASS Trial

Author(s):

EP: 1.Role of NOACs in Venous Thromboembolism and COMPASS Trial

EP: 2.COMPASS Trial: Subgroup Analysis and Implications

EP: 3.Rationale and Study Design of the VOYAGER PAD Trial

EP: 4.Case 1: Antithrombotic Regimen in High-Risk Patient

EP: 5.Case 1: Choice of Therapy for Peripheral Artery Disease

EP: 6.Case 1: THEMIS Trial and Subgroup Analysis With Revascularization

EP: 7.Case 2: Triple Antiplatelet Therapy in Patients With Stents

EP: 8.Case 2: Combination of Device and Drug for Patients With Stents

EP: 9.Case 2: Relationship Between LDL and Major Adverse CV Events

Related Videos

HCPLive Lipoprotein Apheresis Special Report thumbnail

HCPLive Lipoprotein Apheresis Special Report thumbnail

HCPLive Lipoprotein Apheresis Special Report thumbnail

Linda Gillam, MD, MPH | Credit: Atlantic Health System

Linda Gillam, MD, MPH | Credit: Atlantic Health System

Steve Nissen, MD | Credit: Cleveland Clinic

Harpreet Bhatia, MD: Benefits of Universal Screening for Lp(a) Levels

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.